​

Biofrontera (BFRI) Revenue & Revenue Breakdown

OverviewOwnershipFinancialsChartTranscripts

Biofrontera Revenue Highlights

Latest Revenue (Y)

$34.01M

Latest Revenue (Q)

$7.83M

Main Segment (Y)

Government and Payor Rebates

Biofrontera Revenue by Period

Biofrontera Revenue by Year

DateRevenueChange
2023-12-31$34.01M18.59%
2022-12-31$28.67M18.98%
2021-12-31$24.10M27.86%
2020-12-31$18.85M-28.01%
2019-12-31$26.18M-

Biofrontera generated $34.01M in revenue during NA 2023, up 18.59% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Biofrontera Revenue by Quarter

DateRevenueChange
2024-06-30$7.83M-0.89%
2024-03-31$7.90M-25.43%
2023-12-31$10.60M19.34%
2023-09-30$8.88M51.83%
2023-06-30$5.85M-33.04%
2023-03-31$8.73M-13.91%
2022-12-31$10.14M134.71%
2022-09-30$4.32M-3.03%
2022-06-30$4.46M-54.29%
2022-03-31$9.75M6.36%
2021-12-31$9.17M111.54%
2021-09-30$4.33M-25.98%
2021-06-30$5.86M23.42%
2021-03-31$4.74M-44.66%
2020-12-31$8.57M163.59%
2020-09-30$3.25M35.39%
2020-06-30$2.40M-48.04%
2020-03-31$4.62M-

Biofrontera generated $7.83M in revenue during Q2 2024, up -0.89% compared to the previous quarter, and up 89.67% compared to the same period a year ago.

Biofrontera Revenue Breakdown

Biofrontera Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22Dec 21
Prompt Pay Discounts$6.00K$67.00K$7.00K
Government and Payor Rebates$310.00K$264.00K$157.00K
Co-pay Assistance Program$165.00K$675.00K-
Returns$52.00K$53.00K$180.00K
CoPay Assistance Program--$374.00K

Biofrontera's latest annual revenue breakdown by segment (product or service), as of Dec 23: Government and Payor Rebates (58.16%), Co-pay Assistance Program (30.96%), Returns (9.76%), and Prompt Pay Discounts (1.13%).

Quarterly Revenue by Product

Product/ServiceSep 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21
Prompt Pay Discounts$6.00K$6.00K-$6.00K-$2.00K$39.00K$3.00K$3.00K$17.00K$2.00K$5.00K
Government and Payor Rebates$167.00K$82.00K$79.00K$231.00K$20.00K$39.00K$95.00K$34.00K$63.00K$52.00K$44.00K-
Returns$78.00K$52.00K-$52.00K$51.00K$49.00K---$5.00K$38.00K$142.00K
Co-pay Assistance Program---$145.00K$71.00K$71.00K$266.00K$100.00K----
CoPay Assistance Program--------$150.00K$150.00K$111.00K-
Co Pay Assistance Program-----------$263.00K
Government And Payor Rebates-----------$113.00K

Biofrontera's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Government and Payor Rebates (66.53%), Returns (31.08%), and Prompt Pay Discounts (2.39%).

Biofrontera Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
PTPIPetros Pharmaceuticals$5.82B$1.42M
PROCProcaps Group$409.92M$118.41M
CPIXCumberland Pharmaceuticals$39.55M$9.09M
BFRIBiofrontera$34.01M$7.83M
EVOKEvoke Pharma$5.18M$2.65M
AKANAkanda$2.16M$762.61K
SXTCChina SXT Pharmaceuticals$1.97M$939.58K
SHPHShuttle Pharmaceuticals--
IXHLIncannex Healthcare-$12.00K
PRFXPainReform--
RGCRegencell Bioscience--

BFRI Revenue FAQ

What is Biofrontera’s yearly revenue?

Biofrontera's yearly revenue for 2023 was $34M, representing an increase of 18.59% compared to 2022. The company's yearly revenue for 2022 was $28.67M, representing an increase of 18.98% compared to 2021. BFRI's yearly revenue for 2021 was $24.1M, representing an increase of 27.86% compared to 2020.

What is Biofrontera’s quarterly revenue?

Biofrontera's quarterly revenue for Q2 2024 was $7.83M, a -0.89% decrease from the previous quarter (Q1 2024), and a 33.91% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $7.9M, a -25.43% decrease from the previous quarter (Q4 2023), and a -9.53% decrease year-over-year (Q1 2023). BFRI's quarterly revenue for Q4 2023 was $10.6M, a 19.34% increase from the previous quarter (Q3 2023), and a 4.46% increase year-over-year (Q4 2022).

What is Biofrontera’s revenue growth rate?

Biofrontera's revenue growth rate for the last 3 years (2021-2023) was 41.10%, and for the last 5 years (2019-2023) was 29.88%.

What are Biofrontera’s revenue streams?

Biofrontera's revenue streams in c 23 are Prompt Pay Discounts, Government and Payor Rebates, Co-pay Assistance Program, and Returns. Prompt Pay Discounts generated $6K in revenue, accounting 1.13% of the company's total revenue, down -91.04% year-over-year. Government and Payor Rebates generated $310K in revenue, accounting 58.16% of the company's total revenue, up 17.42% year-over-year. Co-pay Assistance Program generated $165K in revenue, accounting 30.96% of the company's total revenue, down -75.56% year-over-year. Returns generated $52K in revenue, accounting 9.76% of the company's total revenue, down -1.89% year-over-year.

What is Biofrontera’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Biofrontera was Government and Payor Rebates. This segment made a revenue of $310K, representing 58.16% of the company's total revenue.